a developer of pharmaceuticals drugs for treatment of central nervous system disorders
Industry Biotechnology
A.I.dvisor indicates that over the last year, ACAD has been loosely correlated with VRTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ACAD jumps, then VRTX could also see price increases.
Ticker / NAME | Correlation To ACAD | 1D Price Change % | ||
---|---|---|---|---|
ACAD | 100% | -3.24% | ||
VRTX - ACAD | 45% Loosely correlated | -2.15% | ||
DNLI - ACAD | 43% Loosely correlated | -3.98% | ||
CCCC - ACAD | 42% Loosely correlated | -7.99% | ||
PRTA - ACAD | 42% Loosely correlated | -6.56% | ||
ADCT - ACAD | 40% Loosely correlated | -6.03% | ||
More |
Ticker / NAME | Correlation To ACAD | 1D Price Change % |
---|---|---|
ACAD | 100% | -3.24% |
central nervous system theme (4 stocks) | 69% Closely correlated | -4.24% |
drugs theme (254 stocks) | 47% Loosely correlated | -4.03% |
stem cells theme (21 stocks) | 42% Loosely correlated | -3.32% |
biotechnology theme (238 stocks) | 26% Poorly correlated | -4.32% |